EUVIMEDEUVIMED entdecken
Crossref

Comprehensive Study on Central Precocious Puberty: Molecular and Clinical Analyses in 90 Patients

Hiromune Narusawa, Tomoe Ogawa, Hideaki Yagasaki, Keisuke Nagasaki iD, Tatsuki Urakawa, Tomohiro Saito, Shun Soneda, Saori Kinjo, Shinichiro Sano, Mitsukazu Mamada, Shintaro Terashita, Sumito Dateki und 6 weitere

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae666 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Hiromune Narusawa und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan. Hauptthemen laut MEDLINE: Puberty, Precocious. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Center for Child Health and Development, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Defects in MKRN3, DLK1, KISS1, and KISS1R and some disorders, such as Temple syndrome (TS14), cause central precocious puberty (CPP). Recently, pathogenic variants (PVs) in MECP2 have been reported to be associated with CPP.

Objective

We aimed to clarify the contribution of (epi)genetic abnormalities to CPP and clinical and hormonal features in each etiology.

Methods

We conducted targeted sequencing for MKRN3, DLK1, MECP2, KISS1, and KISS1R and methylation analysis for screening of imprinting disorders such as TS14 associated with CPP in 90 patients with CPP (no history of brain injuries and negative brain magnetic resonance imaging) and collected their clinical and laboratory data. We measured serum DLK1 levels in 3 patients with TS14 and serum MKRN3 levels in 2 patients with MKRN3 genetic defects, together with some etiology-unknown patients with CPP and controls.

Results

We detected 8 patients with TS14 (6, epimutation; 1, mosaic maternal uniparental disomy chromosome 14; 1, microdeletion) and 3 patients with MKRN3 genetic defects (1, PV; 1, 13-bp deletion in the 5′-untranslated region [5′-UTR]; 1, microdeletion) with family histories of paternal early puberty. There were no patients with PVs identified in MECP2, KISS1, or KISS1R. We confirmed low serum MKRN3 level in the patient with a deletion in 5′-UTR. The median height at initial evaluation of TS14 patients was lower than that of all patients. Six patients with TS14 were born small for gestational age (SGA).

Conclusion

(Epi)genetic causes were identified in 12.2% of patients with CPP at our center. For patients with CPP born SGA or together with family histories of paternal early puberty, (epi)genetic testing for TS14 and MKRN3 genetic defects should be considered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Puberty, PrecociousHumansFemaleMaleChildChild, PreschoolIntercellular Signaling Peptides and ProteinsUbiquitin-Protein LigasesMembrane ProteinsMethyl-CpG-Binding Protein 2KisspeptinsReceptors, Kisspeptin-1MutationInfantCalcium-Binding Proteins

Stichwörter der Autor:innen

MECP2MKRN3central precocious pubertyimprinted genesimprinting disorderstemple syndrome

Substanzen

MKRN3 protein, humanDLK1 protein, humanIntercellular Signaling Peptides and ProteinsKISS1 protein, humanUbiquitin-Protein LigasesMembrane ProteinsMECP2 protein, humanMethyl-CpG-Binding Protein 2KisspeptinsReceptors, Kisspeptin-1

Autor:innen und Institutionen

  • Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.
  • Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Chuo 409-3898, Japan.
  • Division of Pediatrics, Department of Homeostatic Regulation and Development, Niigata University Graduate School of Medical and Dental Science, Niigata 951-8510, Japan.
  • Department of Pediatrics, Yamanashi Prefectural Central Hospital, Kofu 400-0027, Japan.
  • Tanaka Growth Clinic, Tokyo 158-0097, Japan.
  • Department of Pediatrics, St. Marianna University School of Medicine, Kawasaki 216-0015, Japan.

ORCID-Profile: Keisuke Nagasaki, Reiko Horikawa, Tsutomu Ogata, Maki Fukami, Masayo Kagami

Förderung

  • National Center for Child Health and Development
  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • The Foundation for Growth Science
  • The Japanese Society for Pediatric Endocrinology Future Development
  • Novo Nordisk Pharma Ltd
  • Takeda Science Foundation

Zitieren

APA

Narusawa, H., Ogawa, T., Yagasaki, H., Nagasaki, K., Urakawa, T., Saito, T., Soneda, S., Kinjo, S., Sano, S., Mamada, M., Terashita, S., Dateki, S., Narumi, S., Naiki, Y., Horikawa, R., Ogata, T., Fukami, M., & Kagami, M. (2025). Comprehensive Study on Central Precocious Puberty: Molecular and Clinical Analyses in 90 Patients. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae666

Vancouver

Narusawa H, Ogawa T, Yagasaki H, Nagasaki K, Urakawa T, Saito T, et al. Comprehensive Study on Central Precocious Puberty: Molecular and Clinical Analyses in 90 Patients. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae666

BibTeX
@article{Narusawa2025,
  author = {Narusawa, Hiromune and Ogawa, Tomoe and Yagasaki, Hideaki and Nagasaki, Keisuke and Urakawa, Tatsuki and Saito, Tomohiro and Soneda, Shun and Kinjo, Saori and Sano, Shinichiro and Mamada, Mitsukazu and Terashita, Shintaro and Dateki, Sumito and Narumi, Satoshi and Naiki, Yasuhiro and Horikawa, Reiko and Ogata, Tsutomu and Fukami, Maki and Kagami, Masayo},
  title = {Comprehensive Study on Central Precocious Puberty: Molecular and Clinical Analyses in 90 Patients},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae666}
}
Kostenlos starten →